BRPI0512090A - derivado 1(beta)-metil carbapenem e processo para a sua preparação - Google Patents

derivado 1(beta)-metil carbapenem e processo para a sua preparação

Info

Publication number
BRPI0512090A
BRPI0512090A BRPI0512090-0A BRPI0512090A BRPI0512090A BR PI0512090 A BRPI0512090 A BR PI0512090A BR PI0512090 A BRPI0512090 A BR PI0512090A BR PI0512090 A BRPI0512090 A BR PI0512090A
Authority
BR
Brazil
Prior art keywords
preparation
methyl carbapenem
beta
derivative
carbapenem derivative
Prior art date
Application number
BRPI0512090-0A
Other languages
English (en)
Inventor
Kyung Ho Yoo
Dong Jin Kim
Yong Koo Kang
Kyung Seok Lee
Gwan Sun Lee
Maeng Sup Kim
Jae Hoon Kang
Original Assignee
Korea Inst Sci & Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Inst Sci & Tech filed Critical Korea Inst Sci & Tech
Publication of BRPI0512090A publication Critical patent/BRPI0512090A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

DERIVADO 1<225>-METIL CARBAPENEM E PROCESSO PARA A SUA PREPARAçãO A presente invenção refere-se a um novo derivado l<225>-meti1 carbapenem, um processo para a sua preparação, e uma composição farmacêutica compreendendo o derivado 1<225>-metil carbapenem ou um seu sal farmaceuticamente aceitável como um ingrediente anti-bacterial ativo.
BRPI0512090-0A 2004-06-14 2005-06-14 derivado 1(beta)-metil carbapenem e processo para a sua preparação BRPI0512090A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20040043752 2004-06-14
PCT/KR2005/001798 WO2005121144A1 (en) 2004-06-14 2005-06-14 1ß-METHYLCARBAPENEM DERIVATIVE AND PROCESS FOR THE PREPARATION THEREOF

Publications (1)

Publication Number Publication Date
BRPI0512090A true BRPI0512090A (pt) 2008-02-06

Family

ID=35503005

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512090-0A BRPI0512090A (pt) 2004-06-14 2005-06-14 derivado 1(beta)-metil carbapenem e processo para a sua preparação

Country Status (10)

Country Link
US (1) US20080039438A1 (pt)
EP (1) EP1765822A1 (pt)
JP (1) JP2008502675A (pt)
KR (1) KR100621782B1 (pt)
CN (1) CN1968953A (pt)
AU (1) AU2005252126B2 (pt)
BR (1) BRPI0512090A (pt)
CA (1) CA2570487A1 (pt)
MX (1) MXPA06014505A (pt)
WO (1) WO2005121144A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101328177B (zh) * 2007-06-15 2011-02-09 山东轩竹医药科技有限公司 氮杂环乙烯基取代的巯基杂环碳青霉烯化合物
CN101891766A (zh) * 2010-07-20 2010-11-24 深圳市海滨制药有限公司 一种β甲基碳青霉烯类抗生素母核的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0060612A1 (en) * 1981-02-04 1982-09-22 Beecham Group Plc Process for the preparation of azabicyclo(3.2.0)-hept-2-ene derivatives
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
ATE201410T1 (de) * 1994-12-12 2001-06-15 Wyeth Lederle Japan Ltd Verfahren zur herstellung von 1-(4,5-dihydro)2- thiazolyl-3-azetidinthiolderivaten
EP1020440A4 (en) * 1997-05-23 2001-08-22 Eisai Co Ltd FOR THE PRODUCTION OF CARBAPENEM USEFUL INTERMEDIATE PRODUCTS AND METHOD FOR THEIR STEREOSELECTIVE SYNTHESIS

Also Published As

Publication number Publication date
JP2008502675A (ja) 2008-01-31
WO2005121144A1 (en) 2005-12-22
AU2005252126B2 (en) 2008-04-10
MXPA06014505A (es) 2007-03-23
KR100621782B1 (ko) 2006-09-19
AU2005252126A1 (en) 2005-12-22
CN1968953A (zh) 2007-05-23
EP1765822A1 (en) 2007-03-28
KR20060048259A (ko) 2006-05-18
CA2570487A1 (en) 2005-12-22
US20080039438A1 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
GEP20135803B (en) Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
PH12012502087A1 (en) Novel hydroxamic acid derivative
WO2006087543A8 (en) Antibacterial piperidine derivatives
ME01456B (me) Fumaratna so (alfa s, beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoksi-alfa-1-naftalenil-beta-fenil-3-kinolinetanola
EP2130552A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-GRP78 ANTIBODY AS AN ACTIVE SUBSTANCE
WO2007022380A3 (en) Bis-aryl amide compounds and methods of use
NO20071667L (no) Farmasoytisk preparat omfattende levetiracetam og fremgangsmate for fremstilling av preparatet
NO20084853L (no) Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni
WO2007138110A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
ECSP10010223A (es) Derivados de aminobenzamida como agentes útiles para el control de parásitos de animales
WO2007148919A8 (en) Bacteriophage having killing activity specific to staphylococcus aureus
WO2010115184A3 (en) Hydroxythienoquinolones and related compounds as anti-infective agents
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
BRPI0612125A2 (pt) compostos da fórmula (i), processo para a fabricação destes, composto da fórmula iiia, composições farmacêuticas, método para o tratamento e/ou profilaxia de doenças associadas à modulação dos receptores cb1 e uso de compostos
WO2008146172A3 (en) Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
WO2009038412A3 (en) Beta-secretase inhibiting compounds
WO2007138112A3 (en) Compounds that interact with ion channels, in particular with ion channels from the kv family
UY30847A1 (es) Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales
WO2009087286A3 (fr) Utilisation d&#39;un derive de 1-n-(halo-3-pyridylmethyle)-n- methylamino-1-alkylamino-2-nitroethylene pour la preparation d&#39;une composition pharmaceutique veterinaire topique pour lutter contre les parasites externes
AR064152A1 (es) Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion.
UY29358A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento
BRPI0607701A2 (pt) composto ou um sal, éster, solvato, estereoisÈmero, tautÈmero ou pró-droga farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de uma quantidade antibacterialmente eficaz de um composto junto com um veìculo farmaceuticamente aceitável, e, método de preparação de um composto
WO2009108017A3 (en) New pyruvate derivatives with neuroprotective effect, process for preparing the same and pharmaceutical composition comprising the same
WO2009038411A3 (en) Beta-secretase inhibiting compounds having oxo-dihydro-pyrazole moiety

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.